澳大利亚制药企业过去十年向主要政党捐款至少770万澳元，但由于联邦披露法存在漏洞，真实捐款规模仍不为人知1。一项新研究发现，企业报告的捐款金额与政党方面报告的接收金额存在明显出入，引发对制药行业政治影响力的关注1。
根据研究数据，制药企业报告向联盟党捐款389万澳元，但联盟党仅报告收到164万澳元；向工党报告捐款381万澳元，工党则报告收到476万澳元1。这些差异反映了现行披露制度的透明度缺陷。当前披露门槛自2015年设定为12800澳元后逐步提高，至2024年已升至16300澳元，意味着许多政治捐款因未达门槛而无需披露1。2027年1月生效的新政治融资披露法将降低门槛至5000澳元，同时设置捐款年度上限50000澳元，预期能增加透明度1。
2024-25年度澳大利亚药物福利计划支出达191亿澳元1。
Australian pharmaceutical firms have donated at least A$7.7 million to the country's major political parties over the past decade, according to a new study, yet significant gaps in federal disclosure requirements obscure the true extent of these contributions.1 Research examining donations from Medicines Australia and its 37 core member companies between 2015 and 2024 revealed stark discrepancies between what enterprises reported giving and what parties reported receiving.1
Companies stated they gave the Coalition A$3.89 million, but the Coalition reported receiving only A$1.64 million, while pharmaceutical firms claimed to have donated A$3.81 million to Labor, which reported A$4.76 million in receipts.1 These inconsistencies highlight loopholes in the current political financing framework. The current disclosure threshold stands at A$12,800, set in 2015, and has gradually increased to A$16,300 as of 2024.1 However, this situation will change when new political financing disclosure laws take effect in January 2027, lowering the threshold to A$5,000 and imposing an annual donation cap of A$50,000.1
The findings emerge amid growing pharmaceutical lobbying efforts and mounting government pressure over drug pricing, with PBS pharmaceutical expenditure reaching A$19.1 billion in the 2024-25 financial year.1
评论
还没有评论，欢迎留下第一条。